Previous Close | 14.69 |
Open | 14.74 |
Bid | 15.31 x 800 |
Ask | 16.10 x 900 |
Day's Range | 14.30 - 14.80 |
52 Week Range | 11.03 - 21.22 |
Volume | |
Avg. Volume | 1,051,913 |
Market Cap | 1.857B |
Beta (5Y Monthly) | 1.10 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.70 |
Earnings Date | May 06, 2024 - May 10, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 21.55 |
Subscribe to Yahoo Finance Plus to view Fair Value for NEO
FT. MYERS, Fla., March 01, 2024--NeoGenomics, Inc. will participate in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, Mass.
The consensus price target hints at a 29.6% upside potential for NeoGenomics (NEO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
NeoGenomics ( NASDAQ:NEO ) Full Year 2023 Results Key Financial Results Revenue: US$591.6m (up 16% from FY 2022). Net...